MedTrace Logo

Left Ventricular Hypertrophy Among Chronic Kidney Disease Patients in Assiut University Hospital

NCT05002010 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-02-22

No results posted yet for this study

Summary

Assess the prevalence and features of left ventricular hypertrophy in patients with chronic kidney disease (CKD) taking into account gender differences and stage of CKD.

To detect factors those predict LVH in CKD.

\*to assess the right ventricle dysfunction in CKD .

Conditions

  • Left Ventricular Hypertrophy
  • Chronic Kidney Diseases

Interventions

DEVICE

Echo

Measure the Left ventricle (LV): IVS (interventricular septum), LVEDD(left ventricle end diastolic dimension ),LVESD((left ventricle end systolic dimension ), PWD(posterior wall dimension), LV systolic dysfunction and LV diastolic dysfunction.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
16 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-28
Primary Completion
2022-11-30
Completion
2022-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05002010 on ClinicalTrials.gov